Convalescent Plasma in the Treatment of COVID 19

Clinical trial NCT04343261 · COMPLETED

Trial details

NCT number: NCT04343261
Sponsor: Trinity Health Of New England
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)COVID Coronavirus

Start date: 2020-04-10
Primary completion: 2020-07-23
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.